Expression of SCUBE2 and BCL2 Predicts Favorable Response in ERα Positive Breast Cancer

Rezvan Esmaeili ¹, Samaneh Mohammadi ¹, Narges Jafarbeik-Iravani ¹, Fatemeh Yadegari ¹, Asiieh Olfatbakhsh ², Mahta Mazaheri ³, Ahmad Kaviani ⁴, Mahdi Rezaee ^1,5, Keivan Majidzadeh-A ¹ *

Cited by CrossRef: 5

1- Naamneh Elzenaty R, Kouri C, Martinez de Lapiscina I, Sauter K, Moreno F, Camats-Tarruella N, Flück C. NR5A1/SF-1 Collaborates with Inhibin α and the Androgen Receptor. IJMS. 2024;25(18):10109 [Crossref]

2- Vo T, McNeela E, O’Donovan O, Rani S, Mehta J. Mechanism of miRNAs and miRNA-mRNA Regulatory Networks in Modulating Drug Resistance in HER2-Positive Breast Cancer: An Integrative Bioinformatics Approach. Cancers. 2024;16(23):3962 [Crossref]

3- Lin Y, Sahoo B, Gau S, Yang R. The biology of SCUBE. J Biomed Sci. 2023;30(1) [Crossref]

4- Kumar S, Prajapati K, Gupta S. The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer. IJMS. 2022;23(18):10577 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.